
Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 1 of a 3-Part Series
Breast Cancer Update
00:00
Do You Want Your Ovarian Suppression to Work?
The non-adherence and the compliance rates is 49% over 5 years, only 49% of the women complete 5 years of planned adjuvant therapy based on population based datasets. Fortunately at Memorial Sloan Kettering Cancer Center, we have a sexual health therapist, if you will, who runs a sexual health clinic. They use those vaginal low dose estrogen preparations. The data has been okay that it's not necessarily getting systemically absorbed and will not lead to recurrence. We're comfortable that that will help them with their quality of life and not cause recurrence.
Play episode from 42:08
Transcript


